IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on January 1, 2010
(Investigative Ophthalmology and Visual Science. )
© 2009 by The Association for Research in Vision and Ophthalmology, Inc.
doi:10.1167/iovs.09-3917

This Article
Right arrow Full Text (P<P[PDF])
Right arrow All Versions of this Article:
iovs.09-3917v1
51/1/535    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deissler, H. L
Right arrow Articles by Lang, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deissler, H. L
Right arrow Articles by Lang, G. E.

Article

Inhibition of Protein Kinase C Is not Sufficient to Prevent or Revert Effects of VEGF165 on Tight Junction Protein Claudin-1 and Permeability in Microvascular Retinal Endothelial Cells

Heidrun L Deissler 1*, Helmut Deissler 2, and Gabriele E. Lang 3

1 Department of Ophthalmology, University of Ulm Medical School, Ulm, Germany
2 Department of Obstetrics and Gynecology, University of Ulm Medical School, Ulm, Germany
3 Ophthalmology, University Eye Hospital, Ulm, Germany; Department of Ophthalmology, University of Ulm Medical School, Ulm, Germany

* To whom correspondence should be addressed. E-mail: heidrun.deissler{at}uniklinik-ulm.de.


   Abstract

Purpose: Pathogenesis of diabetic macular edema is driven by deregulated expression of VEGF. Studying long-term exposure of immortalized bovine retinal endothelial cells (iBREC) to VEGF165 clearly confirmed the role of the tight junction protein claudin-1 which almost completely disappeared within 24 h, an effect that could be completely reverted by addition of the VEGF-binding Fab fragment ranibizumab. In this study, we investigated if this VEGF165-induced loss of claudin-1 is regulated by protein kinase C (PKC) and indeed affects the barrier function of iBREC. Methods: The effects of various PKC inhibitors on claudin-1 expression and cellular localization in iBREC treated with VEGF165 for up to 2 days were studied by Western blot analyses and immunofluorescence microscopy. Permeability of cell layers was determined by transendothelial electrical resistance measurements. Results: Activation of PKC led to decreased expression of claudin-1 which could be blocked by inhibitors of PKC {delta}. However, none of the PKC inhibitors significantly affected VEGF165-induced effects on cellular localization or expression of claudin-1. Also VEGF165-induced higher permeability of iBREC layers could be reverted or prevented by ranibizumab but not by PKC inhibitors. In addition, low claudin-1 expression and its delocalization from the plasma membrane were significantly associated with elevated permeability. Conclusion: We showed that in iBREC PKC isoforms are not crucially involved in VEGF165-initiated signal transduction affecting permeability and expression of claudin-1. This is in contrast to published results concerning only short-term effects of VEGF165. We also confirmed that claudin-1 is a highly relevant component of functional tight junctions in retinal endothelial cells.

Key Words: diabetic retinopathy, tight junction, immortalization, retinal endonthelial cell, protein kinase C, VEGF inhibitor







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2009 by the Association for Research in Vision and Ophthalmology